7.130
−1,79%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -72.2% | -104.2% | 0 / 3 | +10.9% | -26.42 pp | -18.27 pp | +0.8% | 0.51 | 94.07 | 108 | +10,9% | 11,4 | −59,3% | 94.07 | 132.06 | −28,8% |
| Pts | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 7.130 (close price on 2026-10-19)EPS (TTM): 75,8
Financial charts
1.Revenue & growth
VND bn108Q3/26
1.Revenue & growth
VND bn108Q3/26
2.Profit & growth
VND bn11,4Q3/26
3.Profit mix (Penman)
VND bn6,76Q3/26
4.Margins & cost structure
%15.6%Q3/26
5.Returns & cash cycle
% · days1.0%Q3/26
6.Earnings quality & cash
VND bn35,4Q3/26
7.Asset structure
VND bn1.339Q3/26
8.Funding & debt health
VND bn · times1.339Q3/26
9.Revenue backlog
VND bn27,7Q3/26
10.Valuation
times · %95,8×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %161Q3/26
Adjusted EPS growth, latest quarter
-72.2%
Average adjusted EPS growth, 3 quarters
-105%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26